Winning Stocks From U.S. Sovereign Wealth Fund
When President Trump signed an executive order for the U.S. to create a government-run sovereign wealth fund, it created stock opportunities for investors.Countries that are rich in resources typically have a wealth fund. For example, Norway, China, and Singapore have natural resources to back their fund. By contrast, the U.S. runs a deficit and depends on Treasury debt to raise funds. Still, this fund gives the U.S. another way to compete with countries that run such a fund.Trump suggested using the fund to TikTok. This mention suggests that U.S. social networking stocks are the winning picks. Meta Platforms (META), Snapchat (SNAP), and Pinterest (PINS) may rise in value if the U.S. sovereign fund fails to acquire TikTok.Investors should grow increasingly wary of holding long-term Treasury bonds. The fund would decrease the government’s reliance on selling debt to raise funds. That would hurt the 10-year Treasury bonds and longer. Consider avoiding exchange-traded funds like the 10+ Year Treasury (IEF) bond and the 20+ Year Treasury (TLT).Cryptocurrencies and crypto platforms like Coinbase (COIN) would perform well. Bitcoin (BTC-USD) and Ethereum (ETH-USD) would rise in value. The fund would likely accumulate positions in both. Consumers would expect more stability in the crypto space. That would help Coinbase add more users to its platform.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


